Why are experts excited about KarXT, a novel muscarinic acetylcholine receptor agonist that, if approved, is poised to revolutionize schizophrenia treatment?
Sam Clark, MD, PhD
Advertisement
Dr Clark is the founder and CEO of Terran Biosciences.
Articles by Sam Clark, MD, PhD
Sam Clark, MD, PhD, the founder and CEO of Terran Biosciences shared all you need to know about the development of their schizophrenia treatment, TerXT.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Increased Risk of Death in Patients With Dementia Found Related to Common Hospice Medications
2
Treating Mental Illness During Pregnancy the Same as Any Medical Illness: In Conversation With Jennifer L. Payne, MD
3
The Use of Aripiprazole for Bipolar Disorder
4
FDA Accepts NDA for CTx-1301 for Treatment of ADHD
5
